PEPTIDE
Sermorelin
Growth Hormone Releasing Hormone (1-29)
5mg $45Sermorelin is a synthetic analog of the first 29 amino acids of Growth Hormone Releasing Hormone (GHRH). It represents the shortest fully functional fragment of GHRH and has been studied extensively for its interaction with the GHRH receptor in pituitary research.
GHRH Receptor Agonist
Binds and activates the growth hormone releasing hormone receptor (GHRHR), studied in neuroendocrine signaling research.
Minimal Active Fragment
Represents the shortest biologically active N-terminal fragment of the 44-amino acid native GHRH peptide.
Pituitary Research Tool
Used as a diagnostic and research tool for studying growth hormone secretion dynamics in laboratory settings.
Sermorelin: A review of its use in the diagnosis and treatment of growth hormone deficiency
Review of sermorelin's pharmacology, receptor binding characteristics, and utility in growth hormone axis research.
| Product Name | Sermorelin (GHRH 1-29) |
| CAS Number | 86168-78-7 |
| Molecular Formula | C₁₄₉H₂₄₆N₄₄O₄₂S |
| Molecular Weight | 3357.88 Da |
| Purity | ≥99% (HPLC) |
| Physical Form | White Lyophilized Powder |
| Storage | -20°C, protected from light |
| Certification | Third-party HPLC & MS verified |
| Intended Use | Research and laboratory use only |
